Concordance Study for Amplification Detection of Her2 FISH in Breast Tissue Sections
N/A
21 Years
N/A
21 Years
N/A
Not Enrolling
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Concordance Study for Amplification Detection of Her2 FISH in Breast Tissue Sections
Inclusion Criteria:
- Well stained breast tissue slides with bright Her2 signals
Exclusion Criteria:
- Very old slides that were already bleached
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Retrospective
Principal Investigator
Sheila Dobin, Ph.D.
Investigator Role:
Study Director
Investigator Affiliation:
Section Chief, Cytogenetics
Authority:
United States: Institutional Review Board
Study ID:
ASI-Her2F
NCT ID:
NCT01066507
Start Date:
July 2008
Completion Date:
January 2010
Related Keywords:
- Breast Cancer
- Her2
- FISH
- Breast cancer
- Amplification
- Breast Neoplasms
Name | Location |
|---|---|
| PLUS Diagnostics | Lakewood, New Jersey 08701 |
| Scott & White Hospital, Texas | Temple, Texas 76508 |
